National Institute Of Diabetes And Digestive And Kidney Diseases
-
NIH training program in engineering and diabetes competitively renewed for another five years
The National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health has renewed a five-year grant through the NIH’s flagship T32 institutional training grant program. T32 grants provide funding to support students and postdoctoral trainees working in focused areas of research that advance the NIH mission. Read MoreJul 29, 2024
-
VUMC receives $28 million to lead national study of COVID-diabetes link
Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes. Read MoreAug 2, 2023
-
Spraggins, Caprioli win $13.6M from NIH to create “atlases” of the brain, kidney and eye
Researchers in the Vanderbilt University School of Medicine have received three grants totaling $13.6 million from the National Institutes of Health to develop molecular “atlases” of the brain, kidney, eye and other tissues. Read MoreNov 18, 2022
-
Research Snapshot: Hunger signals, including those from cannabinoids, mapped in the brain
Body-made cannabinoids that fine tune hunger signals in the brain have been mapped, with implications for helping those with deadly feeding-related illnesses Read MoreMar 23, 2022
-
Vanderbilt contributes to the ‘Google Earth’ of the human body, starting with the kidney
Vanderbilt contributes molecular imaging data of kidney to the Human BioMolecular Atlas Program, a consortium of 18 diverse collaborative research teams across the United States and Europe. Read MoreNov 12, 2020
-
Diabetes trial sets bar high for retaining research subjects
Research participant Loren Kirkpatrick, right, has worked with Janie Lipps, MSN, and Vanderbilt’s Diabetes Control and Complications Trial since its inception in 1983. (Daniel Dubois / Vanderbilt) Loren Kirkpatrick has been enrolled in the Diabetes Control and Complications Trial (DCCT) at Vanderbilt’s Diabetes Center for nearly half… Read MoreJan 5, 2012